Back to search

Article

N6-methyladenosine (m <sup>6</sup> A) RNA modification restrains antifungal immunity and is a therapeutic target in oral candidiasis

2025-09-07

Abstract excerpt

Fungal infections represent a major global threat, yet to date there is a paucity of effective antifungal drugs and no licensed vaccines to any pathogenic fungi. The commensal pathobiont Candida albicans can cause severe oropharyngeal and mucocutaneous infections in immunocompromised individuals. The initial point of interaction of C. albicans in the oral mucosa is with superficial oral epithelial cells (OECs)....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a62afa42-2168-5cf3-9633-707f2486c862
DOI
10.1101/2025.09.07.674635
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
N6-methyladenosine (m <sup>6</sup> A) RNA modification restrains antifungal immunity and is a therapeutic target in oral candidiasisDOI 10.1101/2025.09.07.674635
Select a neighboring publication to make it the new centre.